Hyundai ADM Bio Inc. (KOSDAQ: 187660)
South Korea
· Delayed Price · Currency is KRW 1,314.00
-73.00 (-5.26%)
Dec 20, 2024, 9:00 AM KST
Hyundai ADM Bio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Other Revenue | - | - | - | -0 | - | 0 |
| Revenue | 10,350 | 13,790 | 14,883 | 13,978 | 13,120 | 10,206 |
| Revenue Growth (YoY) | -28.90% | -7.34% | 6.47% | 6.54% | 28.55% | - |
| Cost of Revenue | 10,220 | 10,627 | 10,560 | 6,772 | 5,720 | 6,249 |
| Gross Profit | 129.7 | 3,163 | 4,323 | 7,205 | 7,400 | 3,957 |
| Selling, General & Admin | 4,359 | 4,490 | 3,804 | 4,083 | 2,824 | 2,160 |
| Research & Development | 10,867 | 1,064 | 587.01 | 627.73 | 727.77 | 679.64 |
| Other Operating Expenses | 138.31 | 123.59 | 122.28 | 106.2 | 88.81 | 140.49 |
| Operating Expenses | 16,338 | 6,627 | 5,078 | 5,115 | 3,870 | 3,106 |
| Operating Income | -16,208 | -3,465 | -754.74 | 2,091 | 3,531 | 850.88 |
| Interest Expense | -890.2 | -743.11 | -509.01 | -52.82 | -19.44 | -24.37 |
| Interest & Investment Income | 683.95 | 952.77 | 667.14 | 177.97 | 127.17 | 94.23 |
| Earnings From Equity Investments | 33.32 | 40.67 | 113.78 | 38.09 | 30.51 | 10.03 |
| Currency Exchange Gain (Loss) | 11.54 | 11.41 | 0.43 | -0.01 | 6.31 | 2.22 |
| Other Non Operating Income (Expenses) | -2,234 | -252.04 | 629.75 | -84.08 | 902.98 | -60.22 |
| EBT Excluding Unusual Items | -18,603 | -3,455 | 147.35 | 2,170 | 4,578 | 872.76 |
| Gain (Loss) on Sale of Investments | 113.95 | 152.08 | -70.79 | - | - | - |
| Gain (Loss) on Sale of Assets | -765.58 | -5.45 | - | 0.33 | 12.81 | - |
| Pretax Income | -19,255 | -3,308 | 76.56 | 2,170 | 4,591 | 872.76 |
| Income Tax Expense | 1.92 | 55.01 | 135.44 | 443.04 | 1,029 | 219.5 |
| Earnings From Continuing Operations | -19,257 | -3,363 | -58.88 | 1,727 | 3,562 | 653.26 |
| Minority Interest in Earnings | 623.97 | 392.98 | 325.39 | 195.58 | 213.17 | 110.97 |
| Net Income | -18,633 | -2,970 | 266.5 | 1,923 | 3,775 | 764.23 |
| Net Income to Common | -18,633 | -2,970 | 266.5 | 1,923 | 3,775 | 764.23 |
| Net Income Growth | - | - | -86.14% | -49.07% | 393.92% | - |
| Shares Outstanding (Basic) | 42 | 42 | 43 | 40 | 34 | 32 |
| Shares Outstanding (Diluted) | 42 | 46 | 45 | 40 | 34 | 32 |
| Shares Change (YoY) | 0.00% | 0.94% | 13.32% | 15.87% | 8.84% | - |
| EPS (Basic) | -440.42 | -70.21 | 6.22 | 48.23 | 109.72 | 24.18 |
| EPS (Diluted) | -440.42 | -70.21 | 6.22 | 48.00 | 109.72 | 24.18 |
| EPS Growth | - | - | -87.05% | -56.25% | 353.81% | - |
| Free Cash Flow | -14,702 | -15,513 | -512.83 | -384.44 | 5,247 | 1,205 |
| Free Cash Flow Per Share | -347.52 | -340.23 | -11.35 | -9.64 | 152.53 | 38.12 |
| Gross Margin | 1.25% | 22.94% | 29.05% | 51.55% | 56.41% | 38.77% |
| Operating Margin | -156.60% | -25.12% | -5.07% | 14.96% | 26.91% | 8.34% |
| Profit Margin | -180.02% | -21.54% | 1.79% | 13.75% | 28.77% | 7.49% |
| Free Cash Flow Margin | -142.05% | -112.49% | -3.45% | -2.75% | 40.00% | 11.81% |
| EBITDA | -14,552 | -1,906 | 330.96 | 2,792 | 4,064 | 1,350 |
| EBITDA Margin | -140.60% | -13.82% | 2.22% | 19.98% | 30.98% | 13.23% |
| D&A For EBITDA | 1,656 | 1,559 | 1,086 | 701.62 | 533.63 | 499 |
| EBIT | -16,208 | -3,465 | -754.74 | 2,091 | 3,531 | 850.88 |
| EBIT Margin | -156.60% | -25.12% | -5.07% | 14.96% | 26.91% | 8.34% |
| Effective Tax Rate | - | - | 176.91% | 20.42% | 22.42% | 25.15% |
| Advertising Expenses | - | 262.18 | 108.01 | 4.95 | 20.42 | 6 |
Source: S&P Capital IQ. Standard template. Financial Sources.